Please login to the form below

Not currently logged in
Email:
Password:

Creon

This page shows the latest Creon news and features for those working in and with pharma, biotech and healthcare.

Allergan eyes early 2017 European launch for Enzepi

Allergan eyes early 2017 European launch for Enzepi

The CHMP's recommendation for Enzepi is likely to be translated into a full approval from the European Commission by August, at which point it will compete with Mylan's Creon ... Enzepi is already licensed in the US, where it is branded as Zenpep and

Latest news

  • AbbVie is not looking at another big acquisition, says CEO AbbVie is not looking at another big acquisition, says CEO

    Pancreatic enzyme replacement product Creon also had a strong quarter, rising 47% to $148m.

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    Investors have been keen to see substance in AbbVie beyond Humira - which loses patent protection in 2016 - and Gonzalez emphasised double-digit gains for its specialty products including Synthroid, Creon, Zemplar ... Pancreatic enzyme replacement

  • AbbVie expects Humira to drive growth in inaugural guidance AbbVie expects Humira to drive growth in inaugural guidance

    Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism

  • Abbott wins FDA approval for infant CF dose

    Abbott has secured approval for an infant-specific dose of CREON (pancrelipase) to treat exocrine pancreatic insufficiency caused by cystic fibrosis (CF). ... The pancreatic enzymes in CREON capsules work directly in the intestines to help break down fats

  • Abbott plans Solvay layoffs

    Solvay's product portfolio includes the testosterone gel AndroGel, the progesterone capsule Prometrium, and the pancreatic enzyme replacement therapy Creon (pancreatin).

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics